Opto’s subsidiary EuroCor becomes first ever to complete Aortic Valvuloplasty using Drug eluting balloon DIOR Opto Circuits completes acquisition of US-based Criticare Systems Inc Opto Circuits FY08 consolidated net profit up 81% at Rs 132.39 cr Board recommends 50% dividend, seven for ten bonus Opto Circuits posts 99% growth in profits for Q3 - Nine-months
Opto Circuits receives USFDA approval for its New Gen. Pulse Oximeters Opto Circuits Q2FY08 met sales vaults 121.19% at Rs.123.76 Cr. Opto’s subsidiary EuroCor becomes first ever to receive CE accreditation for DIOR - a drug coated balloon dilation catheter
Opto Circuits subsidiary Bags CE accredition for Dilation Catheters and Guide Wires
Eurocor bags fresh orders from Brazil, Egypt
Opto subsidiary EuroCOR signs distribution agreement for marketing stents in Germany & Switzerland
Opto Circuits acquires EuroCOR GmbH in Germany
Opto Circuits’s Net Profit zooms by 106.22% in Q1 FY07
Opto Circuits posts 120% growth in profits for Q3
Opto Circuits’ subsidiary becomes world’s first to design Polymer-free stent system
Opto Circuits’s Net Profit zooms by 110% in Q2 FY07
Press Coverage
Home | About Opto | Vision | Subsidiaries | Geographical Spread | Management | Design & Engineering | Turnkey Solutions | New Products | Latest Happening | Set up | Manufacturing | Testing | Quality Systems | Technologies | Health Care Products | Opto Electronics Products | ISO | CE | FDA | EOU | Star Status | OEM supplies | Press Releases | Overseas | Indigenous | Why Opto | Contact us
